Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Norlase riceve l'autorizzazione FDA 510(k) e il marchio CE per l'oftalmoscopio indiretto laser (LIO) a scansione di pattern LYNX™
  • USA - čeština
  • USA - Deutsch
  • USA - Polski
  • USA - español
  • USA - slovenčina
  • USA - Français
  • USA - English
  • USA - English

Norlase Logo

News provided by

Norlase

Jan 27, 2025, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Il primo LIO al mondo con funzionalità di scansione di pattern integrate

BALLERUP, Danimarca e REDWOOD CITY, California, 27 gennaio 2025 /PRNewswire/ -- Norlase, uno dei principali produttori mondiali di laser oftalmici che sviluppa soluzioni laser di nuova generazione, ha annunciato oggi il lancio commerciale immediato e la concessione sia dell'autorizzazione FDA 510(k) sia del marchio CE per Norlase® LYNX™, il primo e unico oftalmoscopio indiretto laser a scansione di pattern al mondo. LYNX è alimentato a batteria, offrendo così ai chirurghi una soluzione laser senza fili che consente loro di eseguire trattamenti praticamente ovunque. Il modulo laser e di scansione di pattern è integrato nell'ergonomico visore, eliminando la necessità di una sorgente laser esterna. I chirurghi possono ora muoversi liberamente ed efficacemente durante il trattamento grazie a funzionalità avanzate come un'intuitiva interfaccia utente wireless e il controllo vocale multilingue, che offrono una gamma superiore di opzioni per semplificare il flusso del trattamento.

Continue Reading
Norlase® LYNX™, the world’s first and only pattern scanning laser indirect ophthalmoscope
Norlase® LYNX™, the world’s first and only pattern scanning laser indirect ophthalmoscope

"La risorsa più importante per gli oculisti di oggi è il tempo", spiega Oliver Hvidt, Ceo e co-fondatore di Norlase. "Ecco perché hanno richiesto il modello LIO fin dall'invenzione dei laser a scansione di pattern, avvenuta più di 15 anni fa. Con LYNX, il modello LIO è finalmente arrivato. Trattamenti LIO più rapidi si traducono in meno stress ergonomico, più tempo di qualità con i pazienti e più giornate di attività che terminano in orario. Sono soddisfatto delle capacità del nostro team e grato ai medici che hanno contribuito a guidare lo sviluppo. LYNX è il nostro quarto lancio di prodotto in soli cinque anni e testimonia la nostra continua missione volta a semplificare l'attività oftalmica, massimizzando al contempo l'efficienza e il comfort".

I primi utilizzatori del LIO a scansione di pattern LYNX condividono commenti positivi su questo dispositivo laser.

"Questo dispositivo innovativo unisce la velocità e l'efficienza della tecnologia laser a scansione di pattern a una portabilità e un comfort ineguagliati, stabilendo un nuovo standard per i trattamenti laser indiretti", commenta il dott. Daniel Diaz presso Retina Consultants di Miami. "La portabilità e le affidabili opzioni di scansione laser di pattern lo rendono uno strumento all'avanguardia che ha migliorato significativamente il ritmo e la qualità dei miei trattamenti per la retina".

Norlase prosegue il suo percorso di innovazione con LYNX, il quarto annuncio di prodotto dell'azienda dal 2019. Simile ai suoi predecessori, LYNX è ultracompatto, portatile ed economicamente conveniente, e mira a rendere la tecnologia laser all'avanguardia più accessibile agli oculisti di tutto il mondo. 

Caratteristiche notevoli del LIO a scansione di pattern LYNX 

  • Laser, scanner e sistema di erogazione sono completamente integrati nel visore ultraleggero
  • Alimentato a batteria per la portabilità e la flessibilità del trattamento
  • La tavolozza completa dei pattern include reticoli da 2x2 a 5x5, archi tripli e cerchi
  • Filtri di sicurezza simplyCLEAR per una visualizzazione migliorata
  • Controllo vocale multilingue di pattern e parametri

Informazioni su Norlase
Norlase sviluppa soluzioni laser di nuova generazione per il trattamento del glaucoma e delle patologie della retina. Fondata in Danimarca, è composta da esperti mondiali nel settore dell'oftalmologia, della tecnologia laser, dello sviluppo di dispositivi medici e dell'assistenza clienti. La sua mission consiste nel migliorare l'efficienza dei trattamenti, l'assistenza ai pazienti e la comodità degli oculisti di tutto il mondo. I prodotti Norlase includono LEAF, un fotocoagulatore laser 10 volte più piccolo degli attuali sistemi e che si monta direttamente sulla lampada a fessura; LION, il primo laser verde e LIO completamente integrati; ECHO, il primo laser a scansione di pattern ultraportatile al mondo; e LYNX, il primo LIO a scansione di pattern completamente integrato al mondo. Per saperne di più visitare norlase.com.

Foto - https://mma.prnewswire.com/media/2604986/LYNX_Straight_Pattern.jpg 

Logo - https://mma.prnewswire.com/media/2069368/Norlase_logo_vector_Pantone_802c_Logo.jpg

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Norlase Appoints Jacob Philipsen as Chairman of the Board of Directors

Norlase Appoints Jacob Philipsen as Chairman of the Board of Directors

Norlase today announced the appointment of Jacob Philipsen, CEO of Advalight and co-founder of Norlase, as the new Chairman of the Board of Directors....

Norlase získala schválení FDA 510(k) a označení CE pro nepřímý laserový oftalmoskop se sledováním vzorů LYNX™

Norlase získala schválení FDA 510(k) a označení CE pro nepřímý laserový oftalmoskop se sledováním vzorů LYNX™

Společnost Norlase, přední světový výrobce oftalmologických laserů vyvíjející laserová řešení nové generace, dnes oznámila okamžité zahájení...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Computer & Electronics

Computer & Electronics

Medical Equipment

Medical Equipment

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.